Governments are taking initiatives to help drug addicts. For example, US government has recently funded more than 60 inpatient and outpatient drug treatment centers across the country. The US government also opened a center in support with UNODC’s to develop protocol for treating opiate addicted children. According to UN, there is a need for $250 billion every year to treat drug abuse victims. This shows the potential for drug abuse testing market. This report gives intelligence about the application of drug testing in various types of illicit drugs, competitive landscape of key companies involved in drug testing devices, and market estimation based on current and future growth.
Key players in drug abuse industry include Biomedical Diagnostics, BioMerieux, Abbott Laboratories, Bio-Rad, Dako, DiaSorin, Eiken and Fujirebio, Beckman Coulter.
KEY BENEFITS
The report provide strategic intelligence about key developmental plans adopted by top companies so that future market trends in drug abuse market is justified
Market estimations derived in this report are based on primary and secondary data analysis that provides micro level intelligence of drug abuse market
Key regulatory issues and reimbursement scenario is analyzed in this market to get intelligence about future market growth in drug abuse market
Top investment pockets that generate more growth in terms of revenues are mentioned with info-graphic analysis
Market analysis and intelligence of drug abuse market is performed according to end-users, equipments and geographic segments
KEY MARKET SEGMENTS
GLOBAL MARKET, BY END USERS
Schools and educational institutes
Hospitals and healthcare units
Government and private departments
GLOBAL MARKET, BY EQUIPMENTS
Employment testing
Random testing
Reasonable testing
Post accident testing
Follow-up testing
GLOBAL MARKET, BY GEOGRAPHY
North America
Europe
Asia-pacific
RoW
KEY AUDIENCES
Drug testing device manufacturing companies
Tobacco and alcohol beverage manufacturing companies
Government and private institutions
Research based pharmaceutical companies
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
